|
Volumn 41, Issue 16, 2012, Pages 4955-4964
|
Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase i inhibitor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER CELLS;
CANCER CHEMOTHERAPY;
COMPLEX 1;
DINUCLEAR COPPER COMPLEXES;
DNA BINDING STUDIES;
DRUG DESIGN;
GLYCYL-GLYCINE;
IN-VITRO;
INHIBITORY EFFECT;
LOW CONCENTRATIONS;
METALLOPEPTIDES;
MINOR GROOVES;
MODE OF ACTION;
MOLECULAR DOCKING;
MOLECULAR TARGETS;
OPTICAL METHODS;
OXIDATIVE MECHANISM;
SINGLE CRYSTAL X-RAY DIFFRACTION;
SPECTROSCOPIC METHOD;
STRUCTURAL ELUCIDATION;
STRUCTURE ELUCIDATION;
TOPOISOMERASE I;
AMINO ACIDS;
CHEMOTHERAPY;
COPPER COMPOUNDS;
DNA;
SPECTROSCOPIC ANALYSIS;
X RAY DIFFRACTION;
COMPLEXATION;
ANTINEOPLASTIC AGENT;
COPPER;
DNA;
DNA TOPOISOMERASE INHIBITOR;
GLYCYLGLYCINE;
NITROBLUE TETRAZOLIUM;
SUPEROXIDE DISMUTASE;
ARTICLE;
CHEMICAL STRUCTURE;
CHEMISTRY;
DNA CLEAVAGE;
DRUG DESIGN;
ANTINEOPLASTIC AGENTS;
COPPER;
DNA;
DNA CLEAVAGE;
DRUG DESIGN;
GLYCYLGLYCINE;
MOLECULAR STRUCTURE;
NITROBLUE TETRAZOLIUM;
SUPEROXIDE DISMUTASE;
TOPOISOMERASE I INHIBITORS;
|
EID: 84859258794
PISSN: 14779226
EISSN: 14779234
Source Type: Journal
DOI: 10.1039/c2dt12044e Document Type: Article |
Times cited : (75)
|
References (73)
|